Skip to main content
. 2021 Oct 19;23(10):e22567. doi: 10.2196/22567

Table 1.

Description of severity based on medical prescription.

Corresponding medical treatment Exacerbation type
Increase of ICSa and LABAb + SABAc Mild
Increase of ICS and LABA + SABA + oral prednisoloned Moderate
Increase of ICS and LABA + SABA + oral prednisolone + antibioticse Severe

aICS: inhaled corticosteroid.

bLABA: long-acting β2-agonist.

cSABA: short-acting β2-agonist.

dCourse of 37.5 mg daily for 5 to 10 days.

eAmoxcillin 500 mg × 3 daily for 10 days.